IP Library › Assignment 054402/0865
Patent Assignment
Reel/Frame 054402/0865

License

Recorded: 2020-11-13 Pages: 48
Assignor
GENENTECH, INC.
Executed: 2016-10-25
Assignee
NOVOGEN LIMITED
20 GEORGE STREET, SUITE 502, LEVEL 5, HORNSBY, NSW 2077, AUSTRALIA
Covered Properties (2)
Tricyclic PI3K Inhibitor Compounds and Methods of Use
Patent: 8,883,799 →
Application: 13/326,524 →
Publication: US 2012/0171199
Tricyclic P13K Inhibitor Compounds and Methods of Use
Patent: 9,546,182 →
Application: 14/524,204 →
Publication: US 2015/0079081
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 21, 2012
From: DOTSON, JENNAFER; HEFFRON, TIMOTHY; NDUBAKU, CHUDI; OLIVERO, ALAN G.
To: GENENTECH, INC.
Reel/Frame 028243/0062 →
Assignment of Assignor's Interest May 21, 2012
From: HEALD, ROBERT A.; JONES, GRAHAM E.; KRINTEL, SUSSIE L.; MCLEAN, NEVILLE J.
To: ARGENTA DISCOVERY 2009 LIMITED
Reel/Frame 028243/0198 →
Assignment of Assignor's Interest May 21, 2012
From: ARGENTA DISCOVERY 2009 LIMITED
To: GENENTECH, INC.
Reel/Frame 028243/0255 →
Assignment of Assignor's Interest Jun 15, 2012
From: GENENTECH, INC.
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 028382/0857 →
Assignment of Assignor's Interest Aug 31, 2016
From: F. HOFFMANN-LA ROCHE AG
To: GENENTECH, INC.
Reel/Frame 039602/0394 →
Change of Name Nov 13, 2020
From: NOVOGEN LIMITED
To: KAZIA THERAPEUTICS LIMITED
Reel/Frame 054409/0200 →